首页> 外文期刊>世界中西医结合杂志(英文) >Effects of Yinxingdamo Injection Combined with Oxiracetam Capsule on Cognitive Function and Neurological Deficit in Patients with Acute Cerebral Infarction
【24h】

Effects of Yinxingdamo Injection Combined with Oxiracetam Capsule on Cognitive Function and Neurological Deficit in Patients with Acute Cerebral Infarction

机译:银杏达莫注射液联合奥拉西坦胶囊对急性脑梗死患者认知功能和神经功能缺损的影响

获取原文
获取原文并翻译 | 示例
           

摘要

OBJETTIVE:To observe the effects of Yinxingdamo Injection combined with oxiracetam capsule on cognitive function and neurological deficit in patients with acute cerebral infarction.METHODS:A total of 76 patients with acute cerebral infarction were randomly divided into observation group and control group,with 38 patients in each group.Patients in the control group were treated with conventional western medicine and oxiracetam capsules while patients in the observation group were given Yinxingdamo injection intravenous drip treatment on the basis of the same treatment.After 4 weeks of treatment,the cognitive function of the two groups before and after treatment was observed[Simple Intelligence Scale(MMSE Score),Montreal Cognitive Assessment Scale(MoCA Score)],Neurological Deficit[Chinese Stroke Scale(CSS Score),Daily Life Activity ability(ADL score)],free radical biochemical indicators[malondialdehyde(MDA),oxide dismutase(SOD)]changes,and statistical effects of two groups.RESULTS:After treatment,the total effective rate of the observation group was 92.1%,which was significantly higher than 73.7%of the control group(P<0.05).The MMSE score and MoCA score of the two groups were significantly increased after treatment(P<0.05),and the MMSE score and MoCA score inobservation group were significantly increased after treatment than the control group(P<0.05).The CSS scores of the two groups were significantly decreased after treatment(P<0.05),and the ADL scores were significantly increased(P<0.05).The improvement of CSS score and ADL score in the observation group were significantly better than those in the control group(P<0.05),and serum MDA levels were significantly decreased in both groups after treatment(P<0.05),and SOD levels were significantly increased(P<0.05),and the improvement of MDA and SOD levels in the observation group was significantly better than that in the control group group(P<0.05).CONCLUSION:Yinxingdamo injection combined with oxiracetam capsule can effectively inhibit the oxygen free radical reaction injury in patients with acute cerebral infarction,and significantly improve the symptoms of cognitive dysfunction and neurological deficit in patients.Its curative effect is exact and worthy of clinical application.
机译:目的:观察银杏达莫注射液联合奥拉西坦胶囊对急性脑梗死患者认知功能和神经功能缺损的影响。方法:将76例急性脑梗死患者随机分为观察组和对照组,共38例。对照组患者采用常规西药和奥拉西坦胶囊治疗,观察组患者在相同治疗的基础上给予银杏达莫注射液静脉滴注治疗。治疗4周后,患者的认知功能下降。观察两组治疗前后的差异[简单智力量表(MMSE评分),蒙特利尔认知评估量表(MoCA评分)],神经功能缺损[中风量表(CSS评分),日常生活活动能力(ADL评分)],自由基两组生化指标[丙二醛(MDA),氧化物歧化酶(SOD)]的变化及统计学作用。治疗组观察组总有效率92.1%,显着高于对照组的73.7%(P <0.05)。两组治疗后MMSE评分和MoCA评分均明显升高(P <0.05) ),观察组MMSE评分和MoCA评分治疗后明显高于对照组(P <0.05)。两组CSS评分治疗后明显降低(P <0.05),ADL评分显着观察组CSS评分和ADL评分改善明显优于对照组(P <0.05),治疗后两组血清MDA水平明显降低(P <0.05)。 ),观察组SOD水平明显升高(P <0.05),MDA和SOD水平明显优于对照组(P <0.05)。结论:银杏达莫注射液联合奥拉西坦胶囊可以有效积极抑制急性脑梗死患者的氧自由基反应损伤,明显改善患者的认知功能障碍和神经功能缺损症状,疗效确切,值得临床推广。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号